Banco Santander S.A. (SAN) is a publicly traded Financial Services sector company. As of October 3, 2026, SAN trades at $13.48 with a market cap of $192.51B and a P/E ratio of 0.00. SAN moved +0.60% today. Year to date, SAN is +10.69%; over the trailing twelve months it is +31.50%. Its 52-week range spans $5.54 to $15.05. Rallies surfaces SAN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Sanofi’s Regeneron fix requires extra shot of M&A: Sanofi agreed to pay Regeneron $1 billion upfront to develop four immune treatments, with up to $7 billion in additional milestone payments. Sanofi’s top-selling drug, Dupixent, is set to lose U.S. patent protection in 2031; its sales are expected to fall by nearly €14 billion over the following four years.
| Metric | Value |
|---|---|
| Price | $13.48 |
| Market Cap | $192.51B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.14% |
| 52-Week High | $15.05 |
| 52-Week Low | $5.54 |
| Volume | 6.34M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
SAN analyst coverage data. Average price target: $0.00.